Alpha Pharmaceutical sp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-02-11
Share capital
50,000.00 PLN
Activity description

Alpha Pharmaceutical provides international business consulting for pharmaceutical companies. Its services include market research in EU countries, support with negotiations and manufacturer agreements, registration of medicines, medical devices and supplements, and sales of medicines and APIs.

Registered address
ul. Pirenejska 9/28, 01-493 Warszawa, Poland
Email
Phone
Electronic delivery address
AE:PL-37576-68794-IEFIW-32

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$4,670

Filing timeliness

Financial statements were filed on time, on average 102 days early.

  • 202502/06/2026
  • 202418/03/2025
  • 202315/03/2024
  • 202213/03/2023
  • 202104/04/2022
  • 202006/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing12,978 / 24,570
Top 53%
City · Warszawa17,064 / 56,772
Top 30%
Voivodeship · Mazowieckie23,898 / 76,953
Top 31%
Country · Poland94,917 / 297,266
Top 32%

Results vs industry

Revenue
This companyUSD 910.84kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 33.35kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 865.07kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 344.23kMedianUSD 118.27kAverageUSD 1.54m

Trademarks

The company holds 4 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
LYDEN (word)Z.5144005, 10Protected Jun 4, 2030
SOLISTA (word)Z.5144015, 10Protected Jun 4, 2030
SLANDIX (word)Z.5143985, 10Protected Jun 4, 2030
Mark without a word element (figurative)Z.5107833, 5Protected Feb 28, 2030
ALPHA PHARMACEUTICAL (word)Z.5107843, 5Refused –
MarkProtected until
LYDEN (word)Jun 4, 2030
SOLISTA (word)Jun 4, 2030
SLANDIX (word)Jun 4, 2030
Mark without a word element (figurative)Feb 28, 2030
ALPHA PHARMACEUTICAL (word)–

Authorized Representatives

Wołodymyr Hołubka age 55 – President of the Management Board

Manner of representation

If the management board is a one-person management board, the sole member of the management board is authorized to represent the company. If the management board is a multi-member management board, each member of the management board is authorized to represent the company independently.

Ownership

OwnerSharesShare valueStake
100$13,506.21100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-01-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$299
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$185

Competitors

Name
Thinkpro sp. z o.o.
Atlantic Contract sp. z o.o. sp. k.
TAK Pharma sp. z o.o.
Mahta Intl. sp. z o.o.
Yecopharm sp. z o.o.
Esticon sp. z o.o.
3mind Solutions sp. z o.o.
GJ Pharma sp. z o.o.
Pharmalogics sp. z o.o.
Medis Poland sp. z o.o.

FAQ

Last updated: 2026-10-07